Published in Antimicrob Agents Chemother on April 01, 2004
Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother (2004) 2.84
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother (2005) 1.64
Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. Antimicrob Agents Chemother (2005) 1.54
Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance. J Bacteriol (2007) 1.41
Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis. J Bacteriol (2006) 1.34
Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC. Antimicrob Agents Chemother (2005) 1.24
Antibiotic resistance in Chlamydiae. Future Microbiol (2010) 1.22
Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob Agents Chemother (2005) 1.21
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections. Expert Rev Anti Infect Ther (2013) 1.06
Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. Antimicrob Agents Chemother (2007) 1.05
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis. Antimicrob Agents Chemother (2005) 1.04
Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02
Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicrob Agents Chemother (2010) 1.02
Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples. BMC Infect Dis (2014) 0.94
In vivo and in vitro studies of Chlamydia trachomatis TrpR:DNA interactions. Mol Microbiol (2006) 0.92
A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication. BMC Microbiol (2009) 0.87
Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis (2015) 0.86
Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis. Drugs Today (Barc) (2009) 0.85
In vitro recombinants of antibiotic-resistant Chlamydia trachomatis strains have statistically more breakpoints than clinical recombinants for the same sequenced loci and exhibit selection at unexpected loci. J Bacteriol (2011) 0.83
Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control. Int J Epidemiol (2014) 0.80
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. Antimicrob Agents Chemother (2004) 0.78
Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates. Exp Ther Med (2015) 0.75
Effects of Mentha suaveolens essential oil on Chlamydia trachomatis. Biomed Res Int (2015) 0.75
Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion. Genome Res (2017) 0.75
The Macrolide Antibiotic Renaissance. Br J Pharmacol (2017) 0.75
Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother (1995) 9.40
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature (2001) 6.40
Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie (1987) 4.47
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother (2000) 4.31
Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother (2001) 4.17
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 3.25
Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother (1995) 3.22
The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell (2002) 3.07
The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol (1999) 2.36
Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31
Chlamydial rRNA operons: gene organization and identification of putative tandem promoters. J Bacteriol (1987) 1.97
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis (2000) 1.89
Structural basis for the antibiotic activity of ketolides and azalides. Structure (2003) 1.64
Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother (1997) 1.63
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis (1996) 1.61
Structural insight into the antibiotic action of telithromycin against resistant mutants. J Bacteriol (2003) 1.59
Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother (2002) 1.42
Spontaneous erythromycin resistance mutation in a 23S rRNA gene, rrlA, of the extreme thermophile Thermus thermophilus IB-21. J Bacteriol (2001) 0.90
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects. J Clin Microbiol (2002) 0.86
Misidentification of alpha-hemolytic streptococci by routine tests in clinical practice. Infect Genet Evol (2011) 1.31
Complete genome and proteome of Acholeplasma laidlawii. J Bacteriol (2011) 1.24
Chromosome-specific alpha satellites: two distinct families on human chromosome 18. Genomics (1991) 1.08
Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated. J Antimicrob Chemother (2004) 1.07
Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. Int J Antimicrob Agents (2002) 1.03
Discrimination between Streptococcus pneumoniae and Streptococcus mitis based on sorting of their MALDI mass spectra. Clin Microbiol Infect (2013) 1.03
[MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones]. Antibiot Khimioter (2007) 1.00
Proteins and peptides of the salivary gland secretion of medicinal leeches Hirudo verbana, H. medicinalis, and H. orientalis. Biochemistry (Mosc) (2008) 0.95
Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo. Biochem Biophys Res Commun (2005) 0.90
Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. Eur J Clin Microbiol Infect Dis (2010) 0.90
Adaptation of mycoplasmas to adverse environments: phytopathogenicity and peculiarities of protein expression of vegetative and nonculturable forms of Mycoplasma gallisepticum S6 cells. Dokl Biochem Biophys (2010) 0.88
A MALDI TOF MS-based minisequencing method for rapid detection of TEM-type extended-spectrum beta-lactamases in clinical strains of Enterobacteriaceae. J Microbiol Methods (2008) 0.87
Proteome of the bacterium Mycoplasma gallisepticum. Biochemistry (Mosc) (2009) 0.87
Purification and characterisation of recombinant Bacteroides fragilis toxin-2. Biochimie (2013) 0.85
[The properties of the Pseudomonas aeruginosa bacteriophage phiPMG1]. Bioorg Khim (2012) 0.84
Adaptation of mycoplasmas to adverse growth conditions: morphology, ultrastructure, and genome expression of Mycoplasma gallisepticum S6 cells. Dokl Biochem Biophys (2008) 0.83
Molecular typing of N. gonorrhoeae strains prevalent in the Russian Federation. Bull Exp Biol Med (2003) 0.83
[Gene therapy of chronic infections of the urogenital system using cytotoxic peptides]. Vopr Med Khim (2000) 0.82
[Comparative proteomic characteristic of Mycoplasmas (Mollycutes)]. Bioorg Khim (2011) 0.82
[Comparative genome analysis of Helicobacter pylori strains]. Mol Biol (Mosk) (2003) 0.82
Genetic heterogeneity of Mycoplasma hominis clinical isolates detected during observation of patients with recurrent urogenital inflammation. Bull Exp Biol Med (2001) 0.82
Identification of intracellular Spiroplasma melliferum metabolites by the HPLC-MS method. Biochemistry (Mosc) (2012) 0.82
Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy. Bull Exp Biol Med (2007) 0.81
Comparative analysis of transcription profiles of Helicobacter pylori clinical isolates. Biochemistry (Mosc) (2005) 0.81
[Population identification of Helicobacter pilory isolates from Russia]. Genetika (2005) 0.81
[Primary structure of chromosome-specific human alpha-satellite DNA]. Dokl Akad Nauk SSSR (1988) 0.80
Purification and functional analysis of recombinant Acholeplasma laidlawii histone-like HU protein. Biochimie (2011) 0.80
[Laser microdissection for biology and medicine]. Tsitologiia (2012) 0.79
Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA. Antiviral Res (1999) 0.79
[Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia]. Mol Gen Mikrobiol Virusol (2000) 0.79
[Role of mutations in the A-subunit of Acholeplasma laidlawii PG-8B topoisomerase IV in formation of resistance to fluoroquinolones]. Mol Gen Mikrobiol Virusol (2000) 0.78
[Analysis of the nucleotide sequence of a fragment (92-100%) of the CELO avian adenovirus genome]. Mol Gen Mikrobiol Virusol (1993) 0.78
[Sequence analysis of hexon gene from adenovirus KR95 inducing hydropericardium syndrome in chickens]. Mol Gen Mikrobiol Virusol (2000) 0.78
[Allele Frequency Analysis of Four Single Nucleotide Polymorphisms Locating in Promoter and 5'-Untranslated Regions of ABCAI Gene in Young Men - Survivors From Myocardial Infarction]. Kardiologiia (2004) 0.78
Proteomic analysis methods for characterization of proteins from the salivary gland secretions of the medicinal leech during different seasons. Biochemistry (Mosc) (2007) 0.78
Characterization of the Mycoplasma hominis ftsZ gene and its sequence variability in mycoplasma clinical isolates. Biochem Biophys Res Commun (2002) 0.78
Destabilase-lysozyme of medicinal leech. Multifunctionality of recombinant protein. Biochemistry (Mosc) (2010) 0.77
Proteome analysis of the moss Physcomitrella patens (Hedw.) B.S.G. Biochemistry (Mosc) (2009) 0.77
[Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer]. Vopr Onkol (2010) 0.77
Expression of Chlamydia trachomatis inclusion membrane protein genes IncB and IncC in Escherichia coli. Biochemistry (Mosc) (2006) 0.77
Drift of tetM determinant in urogenital microbiocenosis containing mycoplasmas during treatment with a tetracycline antibiotic. Bull Exp Biol Med (2002) 0.77
[Development of fluoroquinolone (ciprofloxacin) resistance in Mycoplasma hominis in the presence of Hela cells]. Genetika (2002) 0.77
Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetracycline. Bull Exp Biol Med (2007) 0.77
Hepatitis B virus genetic typing using mass-spectrometry. Bull Exp Biol Med (2009) 0.77
Analysis of genetic markers of N. gonorrhoeae resistance to beta-lactam antibiotics. Bull Exp Biol Med (2006) 0.77
[Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels]. Vestn Ross Akad Med Nauk (2015) 0.76
[Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry]. Biomed Khim (2008) 0.76
[Formation of M. hominis and A. laidlawii resistance to fluoroquinolones]. Mol Gen Mikrobiol Virusol (1998) 0.76
Proteome analysis of chloroplasts from the moss Physcomitrella patens (Hedw.) B.S.G. Biochemistry (Mosc) (2010) 0.76
Association of haplotypes of interleukin-10 gene with the risk of cancer. Bull Exp Biol Med (2007) 0.76
[A2144G is the main mutation in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance]. Genetika (2005) 0.76
Recombinant plasmid constructs expressing gene for antimicrobial peptide melittin for the therapy of Mycoplasma and chlamydia infections. Bull Exp Biol Med (2007) 0.76
Experimental Mycoplasma hominis infection of the genital tract in BALB/c mice. Bull Exp Biol Med (2004) 0.76
Site-specific degradation of myelin basic protein by the proteasome. Dokl Biochem Biophys (2009) 0.76
[Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis]. Mol Gen Mikrobiol Virusol (2004) 0.76
[Proteomic technologies for identification of serum potential biomarkers of autoimmune demyelinating polyneuropathies]. Bioorg Khim (2011) 0.76
[Inclusion membrane proteins of Chlamydiaceae]. Biomed Khim (2008) 0.76
Genomic organization, sequence and polymorphism of the human chromosome 4-specific alpha-satellite DNA. Gene (1994) 0.75
Analysis of myelin basic protein fragmentation by proteasome. Acta Naturae (2009) 0.75
Computer analysis of metagenomic data--prediction of quantitative value of specific activity of proteins. Dokl Biochem Biophys (2012) 0.75
[Detection of fluoroquinolone resistance SNPs in gyrA and parC genes of Neisseria gonorrhoeae using MALDI-TOF mass-spectrometry]. Mol Biol (Mosk) (2005) 0.75
Direct evaluation of drug resistance parameters in gonococcus. Bull Exp Biol Med (2007) 0.75
SOD2 gene polymorphism and muscle damage markers in elite athletes. Free Radic Res (2014) 0.75
[Functional degradation of myelin basic protein. Proteomic approach]. Bioorg Khim (2011) 0.75
[Exploration and identification of Physcomitrella patens moss peptides]. Bioorg Khim (2011) 0.75
[Infectious complications in electric cardiac stimulation]. Vestn Khir Im I I Grek (2000) 0.75
[Role of chlamydial infections in obstetric pathology]. Akush Ginekol (Mosk) (1985) 0.75
[Inflammatory diseases of the cervix uteri in pregnant women and their effect on the outcome of pregnancy for the mother and fetus]. Akush Ginekol (Mosk) (1982) 0.75
[Hormonal-metabolic interrelations in children with chronic sinusitis]. Vestn Otorinolaringol (1991) 0.75
[Characteristics of autonomic dystonia in children with vasomotor rhinitis]. Vestn Otorinolaringol (2002) 0.75
[The specific features of the functional status of the pituitary- adrenal and sympatho-adrenal system in children with angiofibromas of the skull base]. Vestn Otorinolaringol (2000) 0.75
[The modern approaches to organization of delivery system in Nizhniy Novgorod]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med (2014) 0.75
Evaluation of antibiotic sensitivity of Chlamydia trachomatis using RT-PCR. Bull Exp Biol Med (2002) 0.75
[Chlamydia as the causative agent in genital and neonatal infections]. Akush Ginekol (Mosk) (1982) 0.75
[Intrauterine pneumonia caused by Chlamydia]. Akush Ginekol (Mosk) (1983) 0.75